Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Osiris Therapeutics Company Profile (NASDAQ:OSIR)

Consensus Ratings for Osiris Therapeutics (NASDAQ:OSIR) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $17.33 (0.37% upside)

Analysts' Ratings History for Osiris Therapeutics (NASDAQ:OSIR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/23/2015TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/20/2015Brean CapitalSet Price TargetBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
12/29/2014Brean CapitalInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2014ZacksReiterated RatingNeutral -> Neutral$14.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2014R. F. LaffertyInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
8/29/2014ZacksDowngradeOutperform -> Neutral$15.00ViewTweet This Rating  Share This Rating on StockTwits
3/17/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/7/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
12/6/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/1/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
10/2/2013Piper JaffrayUpgradeNeutral -> Overweight$21.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2013Jefferies GroupBoost Price TargetUnderperform$3.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2013Piper JaffrayDowngradeOverweight -> Neutral$14.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/8/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Piper JaffrayUpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
(Data available from 2/28/2013 forward)